
15.32MUSD
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US98978N2009
CUSIP
42218Y105
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
-0.86
Dividend Share
-
Dividend Yield
-
Earnings Share
-2.18
Wall Street Target Price
12.00
EPS Estimate Current Year
-2.10
EPS Estimate Next Year
-1.08
EPS Estimate Current Quarter
-0.29
EPS Estimate Next Quarter
-0.3
Most Recent Quarter
-
Revenue TTM
209,025
Gross Profit TTM
66,209
EBITDA
-
Profit Margin
0.00%
Return On Assets TTM
-1001.91%
Return On Equity TTM
-3956.02%
Revenue Per Share TTM
0.056
Qtly Revenue Growth YOY
108.30%
Diluted Eps TTM
-2.18
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
73.2899
Price Book MRQ
21.1296
Enterprise Value Revenue
76
Enterprise Value EBITDA
-3
892.26
1.57%458.99
1.28%300.44
1.09%157.77
0.76%282.72
0.29%900.00
0.00%72.38
-2.81%18.41
-2.02%607.93
-1.11%144.14
-0.55%